Cromos Pharma, where the patients are

Drug Sponsors

NuPathe terminates agreement with Endo, to be acquired by Teva

Wednesday, January 22, 2014 12:28 PM

NuPathe, a specialty pharmaceutical company focused on innovative neuroscience solutions for diseases of the central nervous system, has terminated its agreement and plan to merge with Endo Health Solutions, and its board has withdrawn its recommendation that stockholders accept Endo's offer to acquire all outstanding shares of NuPathe common stock.

More... »

CRF Health eCOA webinar series

Aurobindo acquires commercial operations in seven countries from Actavis

Monday, January 20, 2014 11:59 AM

Aurobindo Pharma, a Hyderabad, India-based manufacturer of generic pharmaceuticals and active pharmaceutical ingredients, has signed a binding offer to acquire commercial operations in seven Western European countries from Actavis, a Dublin, Ireland-based global, integrated specialty pharmaceutical company. Closing of the transaction is conditional on certain antitrust approvals and completion of employee consultation processes.

More... »

Carlyle Group makes binding offer to acquire J&J’s Ortho-Clinical Diagnostics

Friday, January 17, 2014 11:34 AM

Johnson & Johnson has received a binding offer from the Carlyle Group to acquire its Ortho-Clinical Diagnostics business for $4.15 billion. Ortho-Clinical Diagnostics delivers in vitro diagnostic products that give healthcare professionals around the world the knowledge they need to make better treatment decisions sooner.

More... »

Oligomerix relocates, secures lab space from New York Medical College

Wednesday, January 15, 2014 11:11 AM

Oligomerix, a privately-held company pioneering the development of disease modifying therapeutics for Alzheimer's disease and related neurodegenerative disorders, has relocated its corporate headquarters to Valhalla, N.Y. as of Jan. 15, and expanded a lease agreement for additional laboratory space at New York Medical College.

More... »

Moderna launches Onkaido Therapeutics

Wednesday, January 15, 2014 10:59 AM

Moderna Therapeutics, a developer of messenger RNA (mRNA) therapeutics, a treatment modality to enable the in vivo production of therapeutic proteins, has created Onkaido Therapeutics, a new venture focused exclusively on developing mRNA-based oncology treatments.

More... »

Sanofi, Fraunhofer-Gesellschaft create natural product center of excellence

Wednesday, January 15, 2014 10:57 AM

Sanofi and Fraunhofer-Gesellschaft, a European organization for applied research, have launched a natural product center of excellence to accelerate the discovery and development of new therapies to treat infectious diseases, the second leading cause of mortality worldwide, accounting for 10 million deaths in 2011.

More... »

Crealta Pharmaceuticals acquires Savient Pharmaceuticals

Tuesday, January 14, 2014 10:00 AM

Crealta Pharmaceuticals, a new specialty pharmaceutical company, has acquired substantially all of the assets of Savient Pharmaceuticals. Crealta previously announced winning an auction for these assets, signing a definitive acquisition agreement with Savient and the subsequent approval of the transaction by the U.S. Bankruptcy Court for the District of Delaware.

More... »

Regeneron launches new human genetics initiative

Tuesday, January 14, 2014 08:00 AM

Regeneron Pharmaceuticals, a science-based biopharmaceutical company based in Tarrytown, N.Y., has launched a new human genetics initiative via a new wholly owned subsidiary, the Regeneron Genetics Center (RGC).

More... »

goBalto expands internationally

Monday, January 13, 2014 11:48 AM

goBalto, a provider of clinical study start-up solutions, has opened its first international locations, in Singapore and the U.K.

More... »

FutuRx begins operations in Israel

Monday, January 13, 2014 11:45 AM

FutuRx Incubator, formerly BioBoost, which has been granted a license by Israel's Ministry of Economy to establish a biotech incubator in Israel, began operations Jan. 1 at the Weizmann Science Park in Ness Ziona. Thirty to 40 startup companies are planned to be established during the next eight years. FutuRx was incorporated jointly by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development (JJDC) and Takeda Pharmaceutical through its corporate venture arm Takeda Ventures.

More... »

CenterWatch Data Library



Browse by:


April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs